Press Release Nov 10 2023

Biocon Limited has informed the Exchange regarding a press release dated November 10, 2023, titled "Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18%; EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35%;Net Profit at Rs 126 Cr, Up 168%".

View Attachment